| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up
|
Cather, Jennifer
|
|
|
12 |
9 |
p. 2013-2038
|
artikel
|
| 2 |
Chronic Cutaneous Lupus Erythematosus in a White Population: Dermoscopic Characteristics by Clinical Subtype, Lesion Location and Disease Duration
|
Żychowska, Magdalena
|
|
|
12 |
9 |
p. 2117-2133
|
artikel
|
| 3 |
Dupilumab Treatment of Atopic Dermatitis in Routine Clinical Care: Baseline Characteristics of Patients in the PROLEAD Prospective, Observational Study
|
Thaçi, Diamant
|
|
|
12 |
9 |
p. 2145-2160
|
artikel
|
| 4 |
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial
|
Gooderham, Melinda J.
|
|
|
12 |
9 |
p. 2077-2085
|
artikel
|
| 5 |
Efficacy of Calcipotriol/Betamethasone Dipropionate Fixed-Combination Aerosol Foam in the Treatment of Localized Scalp Psoriasis: A Real-Life Case Series from Switzerland
|
Régnier, Antonia
|
|
|
12 |
9 |
p. 2181-2188
|
artikel
|
| 6 |
Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study
|
Li, Gaojie
|
|
|
12 |
9 |
p. 2105-2115
|
artikel
|
| 7 |
High Tolerability, Favorable Safety, and Subjects' Preference for a Single 200 mg/2 mL Tildrakizumab Injection: A Phase I, Open-Label, Randomized Crossover Trial in Healthy Volunteers
|
Kokolakis, Georgios
|
|
|
12 |
9 |
p. 2135-2144
|
artikel
|
| 8 |
Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy
|
Licata, Gaetano
|
|
|
12 |
9 |
p. 2161-2171
|
artikel
|
| 9 |
Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments
|
Bewley, Anthony
|
|
|
12 |
9 |
p. 2039-2048
|
artikel
|
| 10 |
Randomized Clinical Trial of Conventional versus Indoor Daylight Photodynamic Therapy for Treatment of Actinic Cheilitis
|
Arisi, Mariachiara
|
|
|
12 |
9 |
p. 2049-2061
|
artikel
|
| 11 |
Reassurance Techniques Do Not Significantly Impact Confidence in Biosimilars for Psoriasis: A Survey of a Convenience Sample of Individuals with Self-Identified Psoriasis
|
Hrin, Matthew L.
|
|
|
12 |
9 |
p. 2173-2180
|
artikel
|
| 12 |
Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis in the Russian Federation
|
Odnopozova, Liudmila
|
|
|
12 |
9 |
p. 2063-2075
|
artikel
|
| 13 |
Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis
|
Armstrong, April
|
|
|
12 |
9 |
p. 2087-2103
|
artikel
|
| 14 |
Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series
|
Del Rosso, James Q.
|
|
|
12 |
9 |
p. 2189-2200
|
artikel
|
| 15 |
Update on Melasma—Part II: Treatment
|
Cassiano, Daniel P.
|
|
|
12 |
9 |
p. 1989-2012
|
artikel
|
| 16 |
Update on Melasma—Part I: Pathogenesis
|
Espósito, Ana Cláudia C.
|
|
|
12 |
9 |
p. 1967-1988
|
artikel
|
Tijdschrift beschrijving